Medmen Closes Sale Of Florida Assets To Ex-Bluma Wellness Execs
Medmen Enterprises (CSE: MMEN) has finally closed the sale of its Florida operation, albeit at a reduced price. The firm
Read more
MedMen Enterprises
Ascend Wellness Reaches Settlement With MedMen To Acquire New York Assets
It appears that attempting to void a sale agreement with Ascend Wellness Holdings (CSE: AAWH.u) has worked out well for
Read more
Ascend Wellness: Medmen Dispute “Is Nothing More Than A Case Of Sellers Remorse”
Ascend Wellness (CSE: AAWH) last night filed its motion to dismiss defendants counterclaims in its lawsuit against MedMen Enterprises (CSE:
Read more
MedMen Enterprises Chief Revenue Officer Resigns From Role
MedMen Enterprises (CSE: MMEN) is down a member of management. The firm announced late Friday night that it has seen
Read more
Ascend Wellness Takes MedMen To Court, Seeks To Enforce Investment Agreement
It seems Ascend Wellness Holdings, Inc. (CSE: AAWH.U) is not going to take the termination of its New York investment
Read more
Ascend Wellness Continues To Fight Medmen Over New York Asset
After losing its New York investment arrangement with Medmen Enterprises (CSE: MMEN), it appears that Ascend Wellness (CSE: AAWH) is
Read more
Medmen: Canaccord Drops Price Target To $0.35 After Q1 Results
On November 9th, Medmen Enterprises (CSE: MMEN) reported their fiscal first-quarter financial results. The company announced revenues of $39.8 million,
Read more
Medmen: Cantor Reiterates Ratings After Call With Management
On September 23, Medmen Enterprises (CSE: MMEN) reported their fiscal fourth quarter financial results. The company reported revenue of $42
Read more
Medmen: Canaccord Raises Price Target, Rating After Q4 Performance
On September 23, Medmen Enterprises (CSE: MMEN) reported their fiscal fourth-quarter financial results. The company reported revenue of $42 million,
Read more
Medmen Posts Q4 Loss Of $46.2 Million
Medmen Enterprises (CSE: MMEN) last night reminded investors why Canaccord Genuity had a long standing $0.00 price target on the
Read more